Tips to avoid patent pitfalls as market for RNAi-derived therapeutics grows
Anne Marie Clark, senior patent searcher at CAS, looks at ways to protect and commercialise the promise of RNAi
The value and complexity of the patent landscape around RNA interference (RNAi) is increasing, creating special challenges for patent searches to protect IP and maximise its value.
RNAi is claimed in a variety of ways within patents. Standard terminology is not always used, and chemical modifications can be described a variety of ways. These inconsistencies mean that there is no single search strategy that can be used to efficiently and comprehensively retrieve this information from different data sources.